GeoVax Labs, Inc. (GOVX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.20
- As of
Kresmion compiles this page from GOVX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
GeoVax Labs, Inc. (GOVX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-27.
See the full GOVX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GOVX on one page. Preview it with sample data, then open it live with a free account.
Preview the GOVX dossierActive events for GOVX
- mediumEarnings above estimates
Q2-2026: Beat consensus by 67.0%, EPS $-0.97 vs $-2.9376 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 14.7% - EPS $-7.75 vs $-6.7575 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 99.9% - EPS $-0.005 vs $-6.2901 estimate
- mediumEarnings above estimates
Q1-2026: Beat consensus by 41.9% - EPS $-2.62 vs $-4.5084 estimate
FREE, NO ACCOUNT
Every event on GOVX, as it fires
New filings, 13F moves and cross asset events on GOVX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, GOVX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
GOVX against its peers
GOVX's operating margin of -869.3% ranks in the 64th percentile of 6 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-03-31.
| Metric | GOVX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.5M USD | 587536 USD | 64 | 6 |
| Gross margin | n/a | 55.7% | n/a | 5 |
| Operating margin | -869.3% | -3270.0% | 64 | 6 |
| Net margin | -862.3% | -2840.2% | 64 | 6 |
| Return on equity | -561.2% | -203.8% | 11 | 13 |
Peers (19): REVB, CASIF, VRAX, BRTX, MTNB, ONCO, SLXN, CPMV, KAPA, ISCO, OGEN, ACUT, ABPO, GNPX, CLDI, PPBT, DCOY, VIVS, MBIO. Left out: XRTX (no annual filing), ELAB (no annual filing), GPLL (period gap), BIXT (no annual filing), AGNPF (no annual filing), VCNX (period gap). Fiscal periods ending between 2025-03-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (GOVX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow GOVX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to GOVX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.